PHOTOCURE ASA (PHO.OL)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. This filer's financial year end could not be read from its revenue history, so quarters are labelled by the calendar. Amounts in NOK.

Revenue Annual

0 200M 400M 600M 2020: 256.5M 2021: 360.5M 2022: 393.1M 2023: 500.7M 2024: 525.4M 2020 2021 2022 2023 2024

Gross Profit Annual

0 200M 400M 600M 2020: 238M 2021: 336.5M 2022: 370.4M 2023: 474.5M 2024: 494.7M 2020 2021 2022 2023 2024

Operating Income Annual

-60M -40M -20M 0 20M 40M 60M 2020: -36.1M 2021: -5.8M 2022: -49M 2023: 27.8M 2024: 20.4M 2020 2021 2022 2023 2024

Net Income Annual

-75M -50M -25M 0 25M 50M 75M 2020: -22.4M 2021: -30.9M 2022: -71.9M 2023: 979K 2024: -3.3M 2020 2021 2022 2023 2024

Cost of Revenue Annual

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Operating Cash Flow Annual

-30M 0 30M 60M 90M 2020: 15.6M 2021: 23.9M 2022: -2M 2023: 48.3M 2024: 76.8M 2020 2021 2022 2023 2024

Free Cash Flow Annual

-25M 0 25M 50M 75M 2020: 14.4M 2021: 20.2M 2022: -5.6M 2023: 36M 2024: 65.3M 2020 2021 2022 2023 2024

Operating cash flow minus capital expenditure.

Shares Outstanding Annual

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

EPS TTM

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.